In the Vladimir region, the Generium pharmaceutical company has applied for registration of a nasal vaccine against COVID-19 by the Ministry of Health. Mass production of the drug may start next summer. This was announced by the Acting Governor Alexander Avdeev in social networks.
General Director of Generium Daniil Talyansky told TASS reporters that the new vaccine will simply be injected into the nose. It will be milder than the already known vaccines but not inferior to traditional forms in terms of effectiveness. Immunization will be done in two stages and revaccination in one. The new vaccine will be easier to store and its transportation will not require special conditions.
The head of the region explained in social networks that he visited “Generium” together with the presidential envoy to the Central Federal District, Igor Shchegolev, during his working visit to the region. According to Avdeev, he is rooting for the successful launch of a socially significant development of the pharmaceutical company and hopes that it will be of great benefit to people.
Earlier, specialists of Generium developed the first domestic express test for COVID-19. Located in the Vladimir region, the pharmaceutical company has already delivered more than 100 million doses of the Sputnik V vaccine to Russian and foreign markets.